LabCorp 2008 Annual Report Download - page 4

Download and view the complete annual report

Please find page 4 of the 2008 LabCorp annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 58

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58

2 Laboratory Corporation of America® Holdings 2008
Holds the key to
prevention
Litholink Kidney
Stone Program
Many patients describe kidney stones
as the worst pain that they have ever
experienced. Moreover, there is a
high incidence of recurrence among
kidney stone sufferers. It is no wonder
then that patients, physicians and
payers alike welcome an outcome
improvement program that reduces
recurrence by 80 percent and cost
per patient by $2,000 per year.
Litholink, our proprietary program,
provides highly personalized analysis,
treatment, follow-up testing and
ongoing support for kidney stone
treatment and prevention.
Disease Prevention
Stop it before it starts – this is the best possible defi nition of prevention. LabCorp offers
tests that can be used to prevent many diseases and chronic conditions from developing
in the fi rst place. Cholesterol measures, for example, help patients to monitor their
cardiovascular health and make lifestyle choices that can help prevent heart disease.
In these and countless other cases, knowledge is power, and our lab tests convey more
knowledge now than ever before.